Introduction

A++ ketosis prone diabetes (KPD) patients have islet autoantibodies and beta cell
functional reserve despite presenting with diabetic ketoacidosis (DKA) 1, 2 . They are middle-aged and overweight; 50% discontinue insulin therapy within 6-12 months for prolonged periods while maintaining glycemic control 1, 2 . Slowly progressive autoimmune beta cell destruction underlie A++ KPD, hence we measured unmethylated insulin DNA (INS DNA) and methylated INS DNA in A++ KPD versus all other subtypes of KPD patients. We have previously shown that circulating unmethylated INS DNA, produced only in beta cells, is increased in newly diagnosed type 1 diabetes (T1D) patients and falls to control levels 8 weeks later, indicating that it is a marker of ongoing beta cell destruction. Methylated INS DNA, in contrast, is not produced exclusively in beta cells, is elevated in new-onset T1D patients compared with "typical" type 2 diabetes adults (T2D), and is higher in the latter than in obese non-diabetic adults -these data suggest that methylated INS DNA may reflect systemic inflammation associated with islet dysfunction 3 .
Methods
The study was approved by the Institutional Review Board for Human Studies of Baylor College of Medicine. KPD patients were identified after presentation with DKA based on our published criteria and treated with standard management protocols 2, 4 .
All participants were classified by the validated A classification scheme for KPD 1, 2, 4, 5 . For direct group comparisons, two-tailed unpaired t-tests were used. P values < 0.05 were considered significant. Data is reported as means ± SEM.
Results
Of the antibody-positive patients in this cohort, GAD-65 was present in 75.0%, IA-2 in 13.6%, and Zn in 26.2%, and 77.3% had only a single antibody.
The A++ KPD patients had a shorter history of diabetes (P=0.01) and greater mean BMI (P=0.04) than the patients of all other KPD subtypes, but there were no other significant differences between the groups ( This is a different process than in patients with A+-KPD ("typical" autoimmune type 1 diabetes), who lack beta cell functional reserve, remain insulin-dependent following the index after onset of diabetes, suggesting that a more chronic inflammatory process could affect the islets and lead to beta cell dysfunction. This reinforces the concept that A++ KPD patients experience slow, prolonged decline in islet mass or function, as opposed to the rapid destruction of islets characteristic of most children with autoimmune type 1 diabetes 3 . 
Discussion
Conclusion
